Search

Author/Creator Bathurst, Camilla

1. Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study. Issue 9 (6th September 2022)

Authors:
Hughes, Sarah E; McMullan, Christel; Rowe, Anna; Retzer, Ameeta; Malpass, Rebecca; Bathurst, Camilla; Davies, Elin Haf; Frost, Chris; McNamara, Gary; Harding, Rosie; Price, Gary; Wilson, Roger; Walker, Anita; Newsome, Philip N; Calvert, Melanie
Journal:
BMJ open
Issue:
Volume 12:Issue 9(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial. Issue 3 (March 2022)

Authors:
Fisher, Benjamin A; Veenith, Tonny; Slade, Daniel; Gaskell, Charlotte; Rowland, Matthew; Whitehouse, Tony; Scriven, James; Parekh, Dhruv; Balasubramaniam, Madhu S; Cooke, Graham; Morley, Nick; Gabriel, Zoe; Wise, Matthew P; Porter, Joanna; McShane, Helen; Ho, Ling-Pei; Newsome, Philip N; Rowe, An...
Journal:
Lancet
Issue:
Volume 10:Issue 3(2022)
Page Start:
255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search